Company Filing History:
Years Active: 2008
Title: Innovations by Mikael Ulf Johan Dahlström
Introduction
Mikael Ulf Johan Dahlström is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. His work focuses on addressing clinical conditions, including lipid disorders.
Latest Patents
Mikael holds 1 patent related to therapeutic agents. The patent provides the S enantiomer of a compound of formula I, where R represents chloro, trifluoromethyl, or trifluoromethoxy. Additionally, R represents H or fluoro, and R represents a Calkyl group. The invention also includes pharmaceutically acceptable salts, solvates, and prodrugs, along with processes for preparing such compounds. The utility of these compounds lies in treating lipid disorders, whether or not associated with insulin resistance.
Career Highlights
Mikael is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to contribute to innovative solutions in the healthcare sector. His expertise in therapeutic agents has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Mikael has collaborated with notable colleagues, including Eva-Lotte Lindstedt Alstermark and Anna Christina Olsson. These collaborations have further enhanced the development of innovative therapeutic solutions.
Conclusion
Mikael Ulf Johan Dahlström's contributions to the field of pharmaceuticals through his patent and work at AstraZeneca highlight his commitment to advancing healthcare solutions. His innovative approach continues to impact the treatment of clinical conditions effectively.